Literature DB >> 15610171

Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages.

Damien D Pearse1, Francisco C Pereira, Anna Stolyarova, David J Barakat, Mary Bartlett Bunge.   

Abstract

Microglia respond in a stereotypical pattern to a diverse array of pathological states. These changes are coupled to morphological and immunophenotypical alterations and the release of a variety of reactive species, trophic factors and cytokines that modify both microglia and their cellular environment. We examined whether a microglial-produced cytokine, tumour necrosis factor-alpha (TNF-alpha), was involved in the maintenance of microglial activation after spinal cord injury by selective inhibition using TNF-alpha antisense deoxyoligonucleotides (ASOs). Microglia and macrophages harvested from 3 d post-contused rat spinal cord were large and rounded (86.3 +/- 9.6%). They were GSA-IB4-positive (GSA-IB4(+)) (Griffonia simplicifolia lectin, microglia specific; 94.8 +/- 5.1%), strongly OX-42 positive (raised against a type 3 complement/integrin receptor, CD11b; 78.9 +/- 9.1%), ED-1 positive (a lysosomal marker shown to correlate well with immune cell activation; 97.2 +/- 2.6%) and IIA positive (antibody recognizes major histocompatibility complex II; 57.2 +/- 5.6%), indicative of fully activated cells, for up to 48 h after plating. These cells also secreted significant amounts of TNF-alpha (up to 436 pg/microg total protein, 16 h). Fluoroscein isothiocyanate-labelled TNF-alpha ASOs (5, 50 and 200 nm) added to the culture medium were taken up very efficiently into the cells (> 90% cells) and significantly reduced TNF-alpha production by up to 92% (26.5 pg/microg total protein, 16 h, 200 nm TNF-alpha ASOs). Furthermore, few of the treated cells at this time were round (5.4 +/- 2.7%), having become predominantly spindle shaped (74.9 +/- 6.3%) or stellate (21.4 +/- 2.7%); immunophenotypically, although all of them remained GSA-IB4 positive (91.6 +/- 6.2%), many were weakly OX-42 positive and few expressed either ED-1 (12.9 +/- 2.5%) or IIA (19.8 +/- 7.4%). Thus, the secretion of TNF-alpha early in spinal cord injury may be involved in autoactivating microglia/macrophages. However, at the peak of microglial activation after injury, the activation state of microglia/macrophages is not stable and this process may still be reversible by blocking TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610171     DOI: 10.1111/j.1460-9568.2004.03799.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

1.  Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

Authors:  James M Massey; Jeremy Amps; Mariano S Viapiano; Russell T Matthews; Michelle R Wagoner; Christopher M Whitaker; Warren Alilain; Alicia L Yonkof; Abdelnaby Khalyfa; Nigel G F Cooper; Jerry Silver; Stephen M Onifer
Journal:  Exp Neurol       Date:  2007-04-12       Impact factor: 5.330

2.  Viability-dependent promoting action of adult neural precursors in spinal cord injury.

Authors:  Daniele Bottai; Laura Madaschi; Anna M Di Giulio; Alfredo Gorio
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

3.  Targeted induction of differentiation of human bone mesenchymal stem cells into neuron-like cells.

Authors:  Zhaohui Cheng; Qixin Zheng; Weici Wang; Xiaodong Guo; Yongchao Wu; Jin Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

4.  Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.

Authors:  Huixin Xu; Eilrayna Gelyana; Molly Rajsombath; Ting Yang; Shaomin Li; Dennis Selkoe
Journal:  J Neurosci       Date:  2016-08-31       Impact factor: 6.167

5.  A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury.

Authors:  Feng Bao; Jennifer C Fleming; Roozbeh Golshani; Damien D Pearse; Levent Kasabov; Arthur Brown; Lynne C Weaver
Journal:  J Neurotrauma       Date:  2011-05-05       Impact factor: 5.269

6.  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

7.  Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury.

Authors:  Mousumi Ghosh; Luis M Tuesta; Rocio Puentes; Samik Patel; Kiara Melendez; Abderrahman El Maarouf; Urs Rutishauser; Damien Daniel Pearse
Journal:  Glia       Date:  2012-03-27       Impact factor: 7.452

8.  Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury.

Authors:  Mousumi Ghosh; Daniela Garcia-Castillo; Vladimir Aguirre; Roozbeh Golshani; Coleen M Atkins; Helen M Bramlett; W Dalton Dietrich; Damien D Pearse
Journal:  Glia       Date:  2012-08-02       Impact factor: 7.452

9.  Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury.

Authors:  Nader Ghasemlou; Delphine Bouhy; Jingxuan Yang; Rubèn López-Vales; Michael Haber; Thusanth Thuraisingam; Guoan He; Danuta Radzioch; Aihao Ding; Samuel David
Journal:  Brain       Date:  2010-01       Impact factor: 13.501

10.  Purification and molecular cloning of a new galactose-specific lectin from Bauhinia variegata seeds.

Authors:  Luciano S Pinto; Celso S Nagano; Taianá M Oliveira; Tales R Moura; Alexandre H Sampaio; Henri Debray; Vicente P Pinto; Odir A Dellagostin; Benildo S Cavada
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.